Health

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:28 2609

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:18 1351

Concord Medical Announces Changes to the Board

BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced the resignation of Mr. Sha...

2019-12-02 17:39 5486

Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics (01801.HK), a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal anti...

2019-12-02 09:37 5281

USANA was named No. 1 Vitamin and Supplement Brand in Philippines*

Euromonitor announces USANA No. 1 Brand in Philippines SALT LAKE CITY, Dec. 2, 2019 /PRNewswire/ -- USANA, a leader in the health and wellness industry, was named the number one vitamin and dietary supplement brand inPhilippines*. This claim was granted by Euromonitor, the world's leading prov...

2019-12-02 09:00 23727

Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

SUZHOU, China, Dec. 2, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today a...

2019-12-02 08:00 3373

United Imaging Sends a Big Message with New Launches, Collaborations

HOUSTON, Dec. 1, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has begun unveiling new technology and strategic collaborations that showcase significant commitment to U.S. market growth. The company had already announced an agreement...

2019-12-02 02:30 1766

Vieworks to debut all new DR detectors at RSNA 2019

ANYANG, South Korea, Nov. 29, 2019 /PRNewswire/ -- Vieworks, a global leader in X-ray imaging solution, is showcasing the newest DR detector lineup featuring the advanced imaging technology at RSNA 2019 (South hall #1723) from 1 to6 December 2019. Today's X-ray imaging solution providers are fa...

2019-11-29 21:30 3363

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

SHENZHEN, China, Nov. 29, 2019 /PRNewswire/ -- On November 29, 2019, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Epidaza® (Chidamide), an oral subtype-selective histone deacetylase (HDAC) inhib...

2019-11-29 20:22 4078

Tianjin Tongrentang Group Partners with Online Pharmacy Giant 111, Inc.

SHANGHAI, Nov. 29, 2019 /PRNewswire/ -- In a partnership combining one of China's oldest names in pharmaceuticals with one of its newest, 111, Inc. (NASDAQ: YI)("111" or the "Company") is partnering with Tianjin Tongrentang Group. Co., Ltd. to deliver traditional Chinese medicine using big data a...

2019-11-29 20:00 7855

Euromedicom Inaugurates the First Edition of FACE ASEAN in Bali, Indonesia - Southeast Asia

KUALA LUMPUR, Malaysia, Nov. 29, 2019 /PRNewswire/ -- The inaugural of FACE ASEAN is scheduled from 12-13 September 2020 at the Nusa Dua Convention Center inBali, Indonesia. FACE ASEAN is the newest addition to the Euromedicom family, is a meeting intended to meet the needs of the medical aesthet...

2019-11-29 10:32 2566

Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout

HANGZHOU, China and SHAOXING, China, Nov. 29, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Ascle...

2019-11-29 08:00 2720

Concord Medical Schedules 2019 Annual Meeting of Shareholders

BEIJING, Nov. 28, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that it will hold its 201...

2019-11-28 17:30 6400

Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...

2019-11-28 12:10 4470

Mundipharma CEO Raman Singh Wins Executive of The Year at SBR Management Excellence Awards

SINGAPORE, Nov. 28, 2019 /PRNewswire/ -- Mundipharma CEO, Raman Singh has been named Executive of the Year for the third year running by the Singapore Business Review's (SBR) Management Excellence Awards, held at Conrad Centennial Singapore on 26 November. SBR's Management Excellence Awards hono...

2019-11-28 12:00 3838

VISTA Eye Specialist unveils gaming technology for eye treatment

KUALA LUMPUR, Malaysia, Nov. 28, 2019 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the leading Eye Specialists inMalaysia, announces the launch of a neurorehabilitation software - Vivid Vision - that uses virtual reality (VR) games to help binocular vision disorders such as lazy or squint...

2019-11-28 08:00 3683

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

HONG KONG, Nov. 28, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-28 00:34 8946

INC: Higher Nut Consumption May Help Prevent Cognitive Decline in the Elderly

REUS, Spain, Nov. 27, 2019 /PRNewswire/ -- A recent INC-funded study, published inMolecular Nutrition & Food Research[1], showed that a high intake of nuts may help protect the elderly from cognitive decline. Nuts and bra...

2019-11-27 23:44 3328

VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution developer and a member company of the Born2Global Centre, will participate in  RSNA (Radiological Society ofNorth America) 2019 in Chicago, December 1-8. Booth: North Hall Level2, #11132.

2019-11-27 21:30 1764

Golden Meditech Announces FY2019/2020 Interim Results

Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...

2019-11-27 18:52 5154